135 related articles for article (PubMed ID: 31990219)
1. Holistic development of coal tar lotion by embedding design of experiments (DoE) technique: preclinical investigations.
Sharma M; Sharma G; Singh B; Dhiman V; Bhadada SK; Katare OP
Expert Opin Drug Deliv; 2020 Feb; 17(2):255-273. PubMed ID: 31990219
[No Abstract] [Full Text] [Related]
2. Double-blind, randomised, multicentre, parallel group study comparing a 1% coal tar preparation (Exorex) with a 5% coal tar preparation (Alphosyl) in chronic plaque psoriasis.
Goodfield M; Kownacki S; Berth-Jones J
J Dermatolog Treat; 2004 Jan; 15(1):14-22. PubMed ID: 14754644
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis.
Singh P; Gupta S; Abidi A; Krishna A
J Drugs Dermatol; 2013 Aug; 12(8):868-73. PubMed ID: 23986159
[TBL] [Abstract][Full Text] [Related]
4. Coal tar in dermatology.
Roelofzen JH; Aben KK; van der Valk PG; van Houtum JL; van de Kerkhof PC; Kiemeney LA
J Dermatolog Treat; 2007; 18(6):329-34. PubMed ID: 17852640
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate iontophoresis versus coal tar ointment in palmoplantar psoriasis: A pilot study.
Haseena K; George S; Riyaz N; Sasidharanpillai S; Puthussery PV
Indian J Dermatol Venereol Leprol; 2017; 83(5):569-573. PubMed ID: 28731017
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and cosmetic acceptability of liquor carbonis distillate (coal tar) solution 15% as topical therapy for plaque psoriasis.
Brouda I; Edison B; Van Cott A; Green BA
Cutis; 2010 Apr; 85(4):214-20. PubMed ID: 20486463
[TBL] [Abstract][Full Text] [Related]
7. Dermatological exposure to coal tar and bladder cancer risk: a case-control study.
Roelofzen JHJ; Aben KKH; Van de Kerkhof PCM; Van der Valk PGM; Kiemeney LALM
Urol Oncol; 2015 Jan; 33(1):20.e19-20.e22. PubMed ID: 24629496
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
9. Observer-blind, randomized, intrapatient comparison of a novel 1% coal tar preparation (Exorex) and calcipotriol cream in the treatment of plaque type psoriasis.
Tzaneva S; Hönigsmann H; Tanew A
Br J Dermatol; 2003 Aug; 149(2):350-3. PubMed ID: 12932242
[TBL] [Abstract][Full Text] [Related]
10. A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis.
Kerdel FA; Draelos ZD; Tyring SK; Lin T; Pillai R
J Dermatolog Treat; 2019 Jun; 30(4):333-339. PubMed ID: 30207807
[No Abstract] [Full Text] [Related]
11. Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar.
Arbiser JL; Govindarajan B; Battle TE; Lynch R; Frank DA; Ushio-Fukai M; Perry BN; Stern DF; Bowden GT; Liu A; Klein E; Kolodziejski PJ; Eissa NT; Hossain CF; Nagle DG
J Invest Dermatol; 2006 Jun; 126(6):1396-402. PubMed ID: 16614726
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis.
Tham SN; Lun KC; Cheong WK
Br J Dermatol; 1994 Nov; 131(5):673-7. PubMed ID: 7999599
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a new coal tar preparation in the treatment of chronic plaque-type psoriasis.
Langner A; Wolska H; Fraczykowska M
Br J Clin Pract; 1989 Apr; 43(4):148-50. PubMed ID: 2590625
[TBL] [Abstract][Full Text] [Related]
14. Topical tazarotene vs. coal tar in stable plaque psoriasis.
Kumar U; Kaur I; Dogra S; De D; Kumar B
Clin Exp Dermatol; 2010 Jul; 35(5):482-6. PubMed ID: 19874376
[TBL] [Abstract][Full Text] [Related]
15. A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic, plaque type psoriasis.
Smith CH; Jackson K; Chinn S; Angus K; Barker JN
Clin Exp Dermatol; 2000 Nov; 25(8):580-3. PubMed ID: 11167965
[TBL] [Abstract][Full Text] [Related]
16. Limited benefit of combined use of tar-based shampoo with 50 microg/ml calcipotriol solution in scalp psoriasis.
Barrett C; Lowson D; Blades KJ;
J Dermatolog Treat; 2005 Aug; 16(3):175. PubMed ID: 16211775
[No Abstract] [Full Text] [Related]
17. Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis.
Khandpur S; Sharma VK
Clin Exp Dermatol; 2011 Aug; 36(6):613-6. PubMed ID: 21507036
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials.
Lebwohl MG; Sugarman JL; Stein Gold L; Lin T; Israel R
J Drugs Dermatol; 2019 Oct; 18(10):1012-1018. PubMed ID: 31584780
[TBL] [Abstract][Full Text] [Related]
19. Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower Extremities.
Bhatia ND; Vlahovic TC; Green LG; Martin G; Lin T
J Drugs Dermatol; 2019 Oct; 18(10):1029-1036. PubMed ID: 31584782
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis symposium. Topical therapy.
Menter A
Semin Dermatol; 1992 Dec; 11(4 Suppl 1):5-10. PubMed ID: 1337263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
